دورية أكاديمية
Comparative efficacy and safety of anti-PD-1/L1 antibody plus anti-VEGF antibody and anti-PD-1/L1 antibody plus VEGFR-targeted tyrosine kinase inhibitor as first-line therapy for unresectable hepatocellular carcinoma (uHCC): A systematic review and...
| العنوان: | Comparative efficacy and safety of anti-PD-1/L1 antibody plus anti-VEGF antibody and anti-PD-1/L1 antibody plus VEGFR-targeted tyrosine kinase inhibitor as first-line therapy for unresectable hepatocellular carcinoma (uHCC): A systematic review and... |
|---|---|
| المؤلفون: | Jieer, Ying, Zhuo, Yiwen, Li, Jingjing, Lu, Beibei, Zheng, Yuxi |
| المصدر: | Journal of Clinical Oncology; 2023 Supplement 16, Vol. 41, pe16148-e16148, 1p |
| قاعدة البيانات: | Supplemental Index |
| تدمد: | 0732183X |
|---|---|
| DOI: | 10.1200/JCO.2023.41.16_suppl.e16148 |